OLMA

Olema Pharmaceuticals
OLMA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$377.00M
EV
$18.69M
Shares Outstanding
68.42M
Beta
1.93

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$25.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Olema Pharmaceuticals, Inc.

gainify
OLMA

Olema Pharmaceuticals, Inc.

OLMA

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degra...

Sector

Healthcare

Industry

Biotechnology

CEO

Bohen, Sean

Employees

96

Website

olema.com

IPO Date

2020-11-19

Headquarters

780 Brannan Street, San Francisco, California, 94103, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.